Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Other Operating Expenses (2016 - 2021)

Historic Other Operating Expenses for ENDRA Life Sciences (NDRA) over the last 6 years, with Q4 2021 value amounting to $382113.0.

  • ENDRA Life Sciences' Other Operating Expenses rose 9857.87% to $382113.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $1.1 million, marking a year-over-year increase of 8480.65%. This contributed to the annual value of $571040.0 for FY2024, which is 3040.8% down from last year.
  • ENDRA Life Sciences' Other Operating Expenses amounted to $382113.0 in Q4 2021, which was up 9857.87% from $275565.0 recorded in Q3 2021.
  • ENDRA Life Sciences' 5-year Other Operating Expenses high stood at $382113.0 for Q4 2021, and its period low was $1124.0 during Q1 2017.
  • For the 5-year period, ENDRA Life Sciences' Other Operating Expenses averaged around $137124.4, with its median value being $111066.0 (2018).
  • Its Other Operating Expenses has fluctuated over the past 5 years, first tumbled by 7464.47% in 2017, then soared by 943532.03% in 2018.
  • Quarter analysis of 5 years shows ENDRA Life Sciences' Other Operating Expenses stood at $67201.0 in 2017, then crashed by 37.61% to $41928.0 in 2018, then skyrocketed by 298.47% to $167070.0 in 2019, then grew by 15.18% to $192424.0 in 2020, then skyrocketed by 98.58% to $382113.0 in 2021.
  • Its Other Operating Expenses was $382113.0 in Q4 2021, compared to $275565.0 in Q3 2021 and $256763.0 in Q2 2021.